Tolerogenic dendritic cells impede priming of naïve CD8⁺ T cells and deplete memory CD8⁺ T cells (Q44367035)

2 December 2017

Tolerogenic dendritic cells impede priming of naïve CD8⁺ T cells and deplete memory CD8⁺ T cells (English)

1 reference

2 December 2017

1 reference

Sandra Laban

5

0 references

author name string

Fleur S Kleijwegt

1

1 reference

2 December 2017

Diahann T S L Jansen

2

1 reference

2 December 2017

Josefine Teeler

3

1 reference

2 December 2017

Antoinette M Joosten

4

1 reference

2 December 2017

Tatjana Nikolic

6

1 reference

2 December 2017

Bart O Roep

7

1 reference

2 December 2017

language of work or name

English

0 references

publication date

12 November 2012

1 reference

European Journal of Immunology

2 December 2017

1 reference

2 December 2017

43

1 reference

2 December 2017

1

1 reference

2 December 2017

85-92

1 reference

Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass.

2 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

GAD treatment and insulin secretion in recent-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

New hope for immune intervention therapy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

Dendritic cells: specialized and regulated antigen processing machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

Analysis of islet inflammation in human type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

TLR Triggering on Tolerogenic Dendritic Cells Results in TLR2 Up-Regulation and a Reduced Proinflammatory Immune Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

Critical role for TNF in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

Serpins prevent granzyme-induced death in a species-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

Differential Protein Pathways in 1,25-Dihydroxyvitamin D3 and Dexamethasone Modulated Tolerogenic Human Dendritic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

Antigen-specific Treg impair CD8(+) T-cell priming by blocking early T-cell expansion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

Foxp3+ regulatory T cells impede the priming of protective CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

Regulatory T cells and IL-10 independently counterregulate cytotoxic T lymphocyte responses induced by transcutaneous immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

UV irradiation of immunized mice induces type 1 regulatory T cells that suppress tumor antigen specific cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

Proteinase inhibitor-9 expression is induced by maturation in dendritic cells via p38 MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

Transfer of regulatory properties from tolerogenic to proinflammatory dendritic cells via induced autoreactive regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

7 January 2021

Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

7 January 2021

1alpha,25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

7 January 2021

Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242879

7 January 2021

Identifiers

DOI

10.1002/EJI.201242879

1 reference

2 December 2017

1 reference